Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PMVP

PMV Pharmaceuticals Inc

Jun 18 • 04:00PM ET

1.13

+0.03 2.73 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ANIX ANVS COYA CYPH EXOZ FBIO ICCC MCRB PLRX XBIT

| Held by: VTI VXF IWC BTEC AVTM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.48	Insider Own	8.32%	Shs Outstand	53.33M	Perf Week	3.67%
Market Cap	60.26M	Forward P/E	-	EPS next Y	-1.12	Insider Trans	0.00%	Shs Float	48.90M	Perf Month	-13.74%
Enterprise Value	-33.00M	PEG	-	EPS next Q	-0.40	Inst Own	64.41%	Short Float	6.66%	Perf Quarter	-24.67%
Income	-78.34M	P/S	-	EPS this Y	1.13%	Inst Trans	-2.52%	Short Ratio	8.56	Perf Half Y	-4.24%
Sales	0.00M	P/B	0.69	EPS next Y	23.69%	ROA	-58.65%	Short Interest	3.26M	Perf YTD	-9.60%
Book/sh	1.65	P/C	0.64	EPS next 5Y	13.14%	ROE	-63.16%	52W High	1.88 -39.89%	Perf Year	2.73%
Cash/sh	1.75	P/FCF	-	EPS past 3/5Y	2.74% -13.98%	ROIC	-89.06%	52W Low	0.96 17.20%	Perf 3Y	-81.04%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.73% 5.01%	Perf 5Y	-96.68%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-26.14%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.14	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	43.61	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.14	EPS Q/Q	-0.77%	SMA20	-1.78%	Beta	1.36	Target Price	4.33
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-12.47%	Rel Volume	0.60	Prev Close	1.10
Employees	54	LT Debt/Eq	0.00	Earnings	May 12 BMO	SMA200	-13.61%	Avg Volume	380.12K	Price	1.13
IPO	Sep 25, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.07% -	Trades		Volume	227,425	Change	2.73%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)